In the past 12‑18 months, the plant‑based soft capsule market has accelerated through strategic alliances, tech rollouts, and shifting regulatory landscapes, shaping the plant based soft capsule 2029 industry trends. In January 2024, NutraFusion partnered with EcoPolymers Ltd. to co‑develop a biodegradable gelatin‑free shell, cutting production waste by 30 %. Mid‑year, the European nutraceutical leader VitaHealth completed its acquisition of biotech startup GreenCore, gaining proprietary pea‑protein encapsulation technology that enables higher bioavailability at lower temperatures. July saw the launch of BioCapsule™ 2.0, a temperature‑responsive capsule that releases nutrients only in the intestinal tract, garnering FDA “Generally Recognized as Safe” (GRAS) status. Meanwhile, the U.S. Food and Drug Administration introduced new labeling guidelines in October, mandating clear disclosure of plant‑origin ingredients, which has prompted manufacturers to revamp packaging. On the funding front, venture firm GreenVentures injected $45 million into UK‑based PureShell, financing a new plant‑based extrusion line slated for Q3 2025. Collectively, these moves signal a rapid shift toward sustainable, high‑performance soft‑gel solutions across both consumer and enterprise segments.
